Breast cancer subtypes have been characterized based on gene expression patterns [3,4,5], including estrogen receptor (ER)-positive, progesterone receptor (PR)-positive, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative (TN) breast cancer, with each subtype requiring unique management approaches [4]. This evidence concerns the gene ERBB2 and breast carcinoma.